Advertisement
Screener

PFIZER INC (PFE) Other Comprehensive Income (Loss), before Tax

2.8 / 5 stars · 68/120 Roast Me

PFIZER INC Other Comprehensive Income (Loss), before Tax

PFIZER INC (PFE) reported Other Comprehensive Income (Loss), before Tax of $27.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossBeforeTax · last filed 2026-08-04

  • PFIZER INC other comprehensive income (loss), before tax for the quarter ending 2026-06-28 was $27.00M.
  • PFIZER INC other comprehensive income (loss), before tax for the quarter ending 2026-03-29 was $944.00M.
  • PFIZER INC other comprehensive income (loss), before tax for the quarter ending 2025-12-31 was -$2.00M, a 100.43% decline year-over-year.
  • PFIZER INC other comprehensive income (loss), before tax for the quarter ending 2025-09-28 was $413.00M.
  • PFIZER INC other comprehensive income (loss), before tax for fiscal 2025 was -$725.00M, a 308.93% decline from fiscal 2024.
  • PFIZER INC other comprehensive income (loss), before tax for fiscal 2024 was $347.00M, a 41.06% increase from fiscal 2023.
  • PFIZER INC other comprehensive income (loss), before tax for fiscal 2023 was $246.00M.
  • PFIZER INC other comprehensive income (loss), before tax for fiscal 2022 was -$2.61B.
Period endOther Comprehensive Income (Loss), before Tax 3 monthOther Comprehensive Income (Loss), before Tax 3 month as first filedOther Comprehensive Income (Loss), before Tax 6 monthOther Comprehensive Income (Loss), before Tax 6 month as first filedOther Comprehensive Income (Loss), before Tax 9 monthOther Comprehensive Income (Loss), before Tax 9 month as first filedOther Comprehensive Income (Loss), before Tax 12 monthOther Comprehensive Income (Loss), before Tax 12 month as first filed
2026-06-28$27.00M
10-Q · filed 2026-08-04
$970.00M
10-Q · filed 2026-08-04
$969.00M
derived: sum of 3 quarters · filed 2026-08-04
$1.38B
derived: sum of 4 quarters · filed 2026-08-04
2026-03-29$944.00M
10-Q · filed 2026-05-05
$942.00M
derived: sum of 2 quarters · filed 2026-05-05
$1.35B
derived: sum of 3 quarters · filed 2026-05-05
$1.15B
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$411.00M
derived: sum of 2 quarters · filed 2026-02-26
$207.00M
derived: sum of 3 quarters · filed 2026-08-04
-$725.00M
10-K · filed 2026-02-26
2025-09-28$413.00M
10-Q · filed 2025-11-04
$209.00M
derived: sum of 2 quarters · filed 2026-08-04
-$723.00M
10-Q · filed 2025-11-04
-$261.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-29-$204.00M
10-Q · filed 2026-08-04
-$1.14B
10-Q · filed 2026-08-04
-$674.00M
derived: sum of 3 quarters · filed 2026-08-04
-$996.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-30-$932.00M
10-Q · filed 2026-05-05
-$470.00M
derived: sum of 2 quarters · filed 2026-05-05
-$792.00M
derived: sum of 3 quarters · filed 2026-05-05
-$836.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$462.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$140.00M
derived: sum of 2 quarters · filed 2026-02-26
$96.00M
derived: sum of 3 quarters · filed 2026-02-26
$347.00M
10-K · filed 2026-02-26
2024-09-29-$322.00M
10-Q · filed 2025-11-04
-$366.00M
derived: sum of 2 quarters · filed 2025-11-04
-$115.00M
10-Q · filed 2025-11-04
-$182.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$44.00M
10-Q · filed 2025-08-05
$207.00M
10-Q · filed 2025-08-05
$140.00M
derived: sum of 3 quarters · filed 2026-02-26
$310.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$251.00M
10-Q · filed 2025-05-05
$184.00M
derived: sum of 2 quarters · filed 2026-02-26
$354.00M
derived: sum of 3 quarters · filed 2026-02-26
$547.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$67.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$103.00M
derived: sum of 2 quarters · filed 2026-02-26
$296.00M
derived: sum of 3 quarters · filed 2026-02-26
$246.00M
10-K · filed 2026-02-26
2023-10-01$170.00M
10-Q · filed 2024-11-04
$363.00M
derived: sum of 2 quarters · filed 2024-11-04
$313.00M
10-Q · filed 2024-11-04
$192.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-07-02$193.00M
10-Q · filed 2024-08-05
$143.00M
10-Q · filed 2024-08-05
$22.00M
derived: sum of 3 quarters · filed 2025-02-27
-$1.12B
derived: sum of 4 quarters · filed 2025-02-27
2023-04-02-$50.00M
10-Q · filed 2024-05-08
-$171.00M
derived: sum of 2 quarters · filed 2025-02-27
-$1.31B
derived: sum of 3 quarters · filed 2025-02-27
-$2.34B
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$121.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$1.26B
derived: sum of 2 quarters · filed 2025-02-27
-$2.29B
derived: sum of 3 quarters · filed 2025-02-27
-$2.61B
10-K · filed 2025-02-27
2022-10-02-$1.14B
10-Q · filed 2023-11-08
-$2.17B
derived: sum of 2 quarters · filed 2023-11-08
-$2.49B
10-Q · filed 2023-11-08
-$2.63B
derived: sum of 4 quarters · filed 2024-02-22
2022-07-03-$1.02B
10-Q · filed 2023-08-09
-$1.34B
10-Q · filed 2023-08-09
-$1.48B
derived: sum of 3 quarters · filed 2024-02-22
-$2.44B
derived: sum of 4 quarters · filed 2024-02-22
2022-04-03-$321.00M
10-Q · filed 2023-05-10
-$458.00M
derived: sum of 2 quarters · filed 2024-02-22
-$1.42B
derived: sum of 3 quarters · filed 2024-02-22
-$1.57B
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$137.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$1.10B
derived: sum of 2 quarters · filed 2024-02-22
-$1.25B
derived: sum of 3 quarters · filed 2024-02-22
-$519.00M
10-K · filed 2024-02-22
2021-10-03-$959.00M
10-Q · filed 2022-11-09
-$1.11B
derived: sum of 2 quarters · filed 2022-11-09
-$382.00M
10-Q · filed 2022-11-09
$501.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-07-04-$155.00M
10-Q · filed 2022-08-10
$577.00M
10-Q · filed 2022-08-10
$1.46B
derived: sum of 3 quarters · filed 2023-02-23
$2.74B
derived: sum of 4 quarters · filed 2023-02-23
2021-04-04$732.00M
10-Q · filed 2022-05-11
$1.61B
derived: sum of 2 quarters · filed 2023-02-23
$2.90B
derived: sum of 3 quarters · filed 2023-02-23
$2.79B
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$883.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$2.16B
derived: sum of 2 quarters · filed 2023-02-23
$2.06B
derived: sum of 3 quarters · filed 2023-02-23
$243.00M
10-K · filed 2023-02-23
-$335.00M
10-K · filed 2021-02-25
2020-09-27$1.28B
10-Q · filed 2021-11-12
$310.00M
10-Q · filed 2020-11-05
$1.18B
derived: sum of 2 quarters · filed 2021-11-12
-$640.00M
10-Q · filed 2021-11-12
-$1.57B
10-Q · filed 2020-11-05
-$107.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-28-$100.00M
10-Q · filed 2021-08-12
-$14.00M
10-Q · filed 2020-08-06
-$1.92B
10-Q · filed 2021-08-12
-$1.88B
10-Q · filed 2020-08-06
-$1.39B
derived: sum of 3 quarters · filed 2022-02-24
-$1.58B
derived: sum of 4 quarters · filed 2022-02-24
2020-03-29-$1.82B
10-Q · filed 2021-05-13
-$1.87B
10-Q · filed 2020-05-07
-$1.29B
derived: sum of 2 quarters · filed 2022-02-24
-$1.48B
derived: sum of 3 quarters · filed 2022-02-24
-$2.15B
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$534.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$344.00M
derived: sum of 2 quarters · filed 2022-02-24
-$325.00M
derived: sum of 3 quarters · filed 2022-02-24
$48.00M
10-K · filed 2022-02-24
-$262.00M
10-K · filed 2020-02-27
2019-09-29-$190.00M
10-Q · filed 2020-11-05
-$859.00M
derived: sum of 2 quarters · filed 2020-11-05
-$486.00M
10-Q · filed 2020-11-05
-$1.50B
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$669.00M
10-Q · filed 2020-08-06
-$296.00M
10-Q · filed 2020-08-06
-$1.30B
derived: sum of 3 quarters · filed 2021-02-25
-$1.67B
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$372.00M
10-Q · filed 2020-05-07
-$636.00M
derived: sum of 2 quarters · filed 2021-02-25
-$997.00M
derived: sum of 3 quarters · filed 2021-02-25
-$1.44B
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$1.01B
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$1.37B
derived: sum of 2 quarters · filed 2021-02-25
-$1.81B
derived: sum of 3 quarters · filed 2021-02-25
-$1.46B
10-K · filed 2021-02-25
2018-09-30-$361.00M
10-Q · filed 2019-11-07
-$801.00M
derived: sum of 2 quarters · filed 2019-11-07
-$449.00M
10-Q · filed 2019-11-07
-$650.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-07-01-$440.00M
10-Q · filed 2019-08-08
-$88.00M
10-Q · filed 2019-08-08
-$289.00M
derived: sum of 3 quarters · filed 2020-02-27
$649.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-04-01$352.00M
10-Q · filed 2019-05-09
$151.00M
derived: sum of 2 quarters · filed 2020-02-27
$1.09B
derived: sum of 3 quarters · filed 2020-02-27
$1.35B
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$201.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$737.00M
derived: sum of 2 quarters · filed 2020-02-27
$995.00M
derived: sum of 3 quarters · filed 2020-02-27
$1.47B
10-K · filed 2020-02-27
2017-10-01$938.00M
10-Q · filed 2018-11-08
$1.20B
derived: sum of 2 quarters · filed 2018-11-08
$1.67B
10-Q · filed 2018-11-08
-$1.44B
derived: sum of 4 quarters · filed 2019-02-28
2017-07-02$258.00M
10-Q · filed 2018-08-09
$732.00M
10-Q · filed 2018-08-09
-$2.38B
derived: sum of 3 quarters · filed 2019-02-28
-$1.58B
derived: sum of 4 quarters · filed 2019-02-28
2017-04-02$474.00M
10-Q · filed 2018-05-10
-$2.63B
derived: sum of 2 quarters · filed 2019-02-28
-$1.84B
derived: sum of 3 quarters · filed 2019-02-28
-$1.17B
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$3.11B
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$2.32B
derived: sum of 2 quarters · filed 2019-02-28
-$1.65B
derived: sum of 3 quarters · filed 2019-02-28
-$1.69B
10-K · filed 2019-02-28
2016-10-02$793.00M
10-Q · filed 2017-11-09
$794.00M
10-Q · filed 2016-11-10
$1.46B
derived: sum of 2 quarters · filed 2017-11-09
$1.42B
10-Q · filed 2017-11-09
$1.42B
10-Q · filed 2016-11-10
$1.32B
derived: sum of 4 quarters · filed 2018-02-22
2016-07-03$669.00M
10-Q · filed 2017-08-10
$624.00M
10-Q · filed 2017-08-10
$531.00M
derived: sum of 3 quarters · filed 2018-02-22
-$190.00M
derived: sum of 4 quarters · filed 2018-02-22
2016-04-03-$44.00M
10-Q · filed 2017-05-11
-$138.00M
derived: sum of 2 quarters · filed 2018-02-22
-$859.00M
derived: sum of 3 quarters · filed 2018-02-22
-$596.00M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31-$94.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
-$815.00M
derived: sum of 2 quarters · filed 2018-02-22
-$552.00M
derived: sum of 3 quarters · filed 2018-02-22
-$1.71B
10-K · filed 2018-02-22
2015-09-27-$721.00M
10-Q · filed 2016-11-10
-$458.00M
derived: sum of 2 quarters · filed 2016-11-10
-$1.61B
10-Q · filed 2016-11-10
-$6.48B
derived: sum of 4 quarters · filed 2017-02-23
2015-06-28$263.00M
10-Q · filed 2016-08-11
-$890.00M
10-Q · filed 2016-08-11
-$5.76B
derived: sum of 3 quarters · filed 2017-02-23
-$6.00B
derived: sum of 4 quarters · filed 2017-02-23
2015-03-29-$1.15B
10-Q · filed 2016-05-12
-$6.02B
derived: sum of 2 quarters · filed 2017-02-23
-$6.26B
derived: sum of 3 quarters · filed 2017-02-23
-$6.00B
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31-$4.87B
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
-$5.11B
derived: sum of 2 quarters · filed 2017-02-23
-$4.85B
derived: sum of 3 quarters · filed 2017-02-23
-$4.99B
10-K · filed 2017-02-23
2014-09-28-$238.00M
10-Q · filed 2015-11-05
$20.00M
derived: sum of 2 quarters · filed 2015-11-05
-$118.00M
10-Q · filed 2015-11-05
$4.46B
derived: sum of 4 quarters · filed 2016-02-29
2014-06-29$258.00M
10-Q · filed 2015-08-06
$120.00M
10-Q · filed 2015-08-06
$4.69B
derived: sum of 3 quarters · filed 2016-02-29
$4.81B
derived: sum of 4 quarters · filed 2016-02-29
2014-03-30-$138.00M
10-Q · filed 2015-05-07
$4.43B
derived: sum of 2 quarters · filed 2016-02-29
$4.56B
derived: sum of 3 quarters · filed 2016-02-29
$4.41B
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$4.57B
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$4.69B
derived: sum of 2 quarters · filed 2016-02-29
$4.55B
derived: sum of 3 quarters · filed 2016-02-29
$4.52B
10-K · filed 2016-02-29
2013-09-29$121.00M
10-Q · filed 2014-11-06
-$23.00M
derived: sum of 2 quarters · filed 2014-11-06
-$52.00M
10-Q · filed 2014-11-06
-$637.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30-$144.00M
10-Q · filed 2014-08-07
-$173.00M
10-Q · filed 2014-08-07
-$758.00M
derived: sum of 3 quarters · filed 2015-02-27
-$331.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31-$29.00M
10-Q · filed 2014-05-08
-$614.00M
derived: sum of 2 quarters · filed 2015-02-27
-$187.00M
derived: sum of 3 quarters · filed 2015-02-27
-$2.79B
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31-$585.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
-$158.00M
derived: sum of 2 quarters · filed 2015-02-27
-$2.77B
derived: sum of 3 quarters · filed 2015-02-27
-$2.06B
10-K · filed 2015-02-27
2012-09-30$427.00M
10-Q · filed 2013-11-08
-$2.18B
derived: sum of 2 quarters · filed 2013-11-08
-$1.47B
10-Q · filed 2013-11-08
-$5.12B
derived: sum of 4 quarters · filed 2014-02-28
2012-07-01-$2.61B
10-Q · filed 2013-08-09
-$1.90B
10-Q · filed 2013-08-09
-$5.54B
derived: sum of 3 quarters · filed 2014-02-28
-$6.02B
derived: sum of 4 quarters · filed 2014-02-28
2012-04-01$710.00M
10-Q · filed 2013-05-10
-$2.94B
derived: sum of 2 quarters · filed 2014-02-28
-$3.41B
derived: sum of 3 quarters · filed 2014-02-28
-$2.34B
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31-$3.65B
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
-$4.12B
derived: sum of 2 quarters · filed 2014-02-28
-$3.05B
derived: sum of 3 quarters · filed 2014-02-28
-$1.69B
10-K · filed 2014-02-28
2011-10-02-$478.00M
10-Q · filed 2012-11-09
$596.00M
derived: sum of 2 quarters · filed 2012-11-09
$1.95B
10-Q · filed 2012-11-09
2011-07-03$1.07B
10-Q · filed 2012-08-09
$2.43B
10-Q · filed 2012-08-09
2010-12-31-$4.36B
10-K · filed 2013-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64